Cardiology
Endothelial dysfunction can lead to cardiovascular disease in ESRD patients
Published in Heart Disease Weekly, June 19th, 2005
According to recent research from Italy, "High prevalence of atherosclerotic cardiovascular events accounts for much of the mortality among patients suffering from end-stage renal disease (ESRD). Endothelial dysfunction as a pathogenic mechanism might contribute to increasing the cardiovascular risk of ESRD."
M. Bonomini and associates at the Osped Clinicizzato SS Annunziata in Italy explained, "Reduced endothelium-dependent vasodilation has consistently been observed in chronic renal failure patients. Since nitric oxide (NO) is the principal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
Source: Heart Disease Weekly (2005-06-19)
More Articles from Heart Disease Weekly
- Aortic Valve Disease
Researchers link ACE inhibitor use with a lower rate of AVC accumulation - Diagnostics
Automated impedance cardiography reliable during exercise testing - Heart Failure
Researchers find rat useful as reference model for human chronic heart failure - Wegeners Granulomatosis
Researchers note factors leading to accelerated atherosclerosis in WG patients - Acute Coronary Syndrome
Non-ST segment elevation cardiac patients get suboptimal care in Spain - Acute Coronary Syndrome
Statins have quick and early anti-inflammatory effects - More from this issue of Heart Disease Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
